Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Chimeric antigen receptor T cells (CAR-T) represent an innovation but raise issues for healthcare payers because of the uncertainty on impact at market launch, high cost and important organisational impact. Th...